Free Trial
NYSE:PBH

Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis

Prestige Consumer Healthcare logo
$85.34 +0.59 (+0.70%)
Closing price 03/3/2025 03:59 PM Eastern
Extended Trading
$85.38 +0.03 (+0.04%)
As of 03/3/2025 04:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Prestige Consumer Healthcare Stock (NYSE:PBH)

Key Stats

Today's Range
$84.74
$86.18
50-Day Range
$73.91
$87.46
52-Week Range
$62.35
$88.36
Volume
349,292 shs
Average Volume
317,485 shs
Market Capitalization
$4.23 billion
P/E Ratio
19.99
Dividend Yield
N/A
Price Target
$92.60
Consensus Rating
Moderate Buy

Company Overview

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Prestige Consumer Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
88th Percentile Overall Score

PBH MarketRank™: 

Prestige Consumer Healthcare scored higher than 88% of companies evaluated by MarketBeat, and ranked 125th out of 942 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Prestige Consumer Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Prestige Consumer Healthcare has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Prestige Consumer Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Prestige Consumer Healthcare are expected to grow by 5.78% in the coming year, from $4.50 to $4.76 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Prestige Consumer Healthcare is 19.99, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.61.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Prestige Consumer Healthcare is 19.99, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 24.95.

  • Price to Earnings Growth Ratio

    Prestige Consumer Healthcare has a PEG Ratio of 2.69. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Prestige Consumer Healthcare has a P/B Ratio of 2.36. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Prestige Consumer Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    3.43% of the float of Prestige Consumer Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Prestige Consumer Healthcare has a short interest ratio ("days to cover") of 5.9.
  • Change versus previous month

    Short interest in Prestige Consumer Healthcare has recently decreased by 18.84%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Prestige Consumer Healthcare does not currently pay a dividend.

  • Dividend Growth

    Prestige Consumer Healthcare does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Prestige Consumer Healthcare is 44.50%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Prestige Consumer Healthcare will have a dividend payout ratio of 39.92% next year. This indicates that Prestige Consumer Healthcare will be able to sustain or increase its dividend.

  • Read more about Prestige Consumer Healthcare's dividend.
  • Percentage of Shares Shorted

    3.43% of the float of Prestige Consumer Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Prestige Consumer Healthcare has a short interest ratio ("days to cover") of 5.9.
  • Change versus previous month

    Short interest in Prestige Consumer Healthcare has recently decreased by 18.84%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Prestige Consumer Healthcare has a news sentiment score of 1.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Prestige Consumer Healthcare this week, compared to 4 articles on an average week.
  • Search Interest

    Only 1 people have searched for PBH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Prestige Consumer Healthcare insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.60% of the stock of Prestige Consumer Healthcare is held by insiders.

  • Percentage Held by Institutions

    99.95% of the stock of Prestige Consumer Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Prestige Consumer Healthcare's insider trading history.
Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

PBH Stock News Headlines

Zacks Research Has Optimistic Outlook of PBH Q3 Earnings
Research Analysts Offer Predictions for PBH FY2025 Earnings
Jeff Brown's Urgent March 17th Alert
Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.
See More Headlines

PBH Stock Analysis - Frequently Asked Questions

Prestige Consumer Healthcare's stock was trading at $78.09 at the start of the year. Since then, PBH shares have increased by 9.3% and is now trading at $85.34.
View the best growth stocks for 2025 here
.

Prestige Consumer Healthcare Inc. (NYSE:PBH) announced its quarterly earnings data on Thursday, February, 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a trailing twelve-month return on equity of 12.36%.

Prestige Consumer Healthcare's top institutional investors include Vanguard Group Inc. (11.52%), Dimensional Fund Advisors LP (5.88%), Ariel Investments LLC (5.59%) and Victory Capital Management Inc. (3.37%). Insiders that own company stock include Ronald M Lombardi, William P'pool, Mary Beth Fritz and Adel Mekhail.
View institutional ownership trends
.

Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Prestige Consumer Healthcare investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AUO (AUOTY).

Company Calendar

Last Earnings
2/06/2025
Today
3/03/2025
Fiscal Year End
3/31/2025
Next Earnings (Estimated)
5/13/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Personal Products
Current Symbol
NYSE:PBH
Employees
540
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$92.60
High Stock Price Target
$104.00
Low Stock Price Target
$76.00
Potential Upside/Downside
+8.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
19.99
Forward P/E Ratio
18.96
P/E Growth
2.69
Net Income
$209.34 million
Pretax Margin
24.82%

Debt

Sales & Book Value

Annual Sales
$1.12 billion
Cash Flow
$5.01 per share
Price / Cash Flow
17.03
Book Value
$36.10 per share
Price / Book
2.36

Miscellaneous

Free Float
48,745,000
Market Cap
$4.23 billion
Optionable
Optionable
Beta
0.50

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:PBH) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners